Janssen Biotech Inc.

08/01/2022 | Press release | Distributed by Public on 08/01/2022 08:13

STELARA® (ustekinumab) Approved by the U.S. Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis